Mechanism of HIV-1-TAT induction of interleukin-1β from human monocytes: Involvement of the phospholipase C/protein kinase C signaling cascade

Journal of Medical Virology

Volumn 82, Issue 5, 2010, Pages 735-746

  Yang, Yongbo ^a,b   Wu, Jianguo ^a   Lu, Yuanan ^b,c  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF HAWAII   (United States)

Author keywords

HIV; Interleukin 1 ; JNK; NF B; p44 42; Phospholipase C; Protein kinase C; TAT

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COMPLEMENTARY DNA; CYTOKINE; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHOLIPASE C; PROTEIN KINASE C; RECOMBINANT PROTEIN; RNA; TRANSACTIVATOR PROTEIN; UO 126; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMENTIA; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MONOCYTE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; POLYMERASE CHAIN REACTION; PROMOTER REGION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

HIV-1; HUMANS; INTERLEUKIN-1BETA; MONOCYTES; PROTEIN KINASE C; SIGNAL TRANSDUCTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TYPE C PHOSPHOLIPASES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77951002550     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21720     Document Type: Article

References (50)

1. Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L. 1996. The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat Med 2:1371-1375. (Pubitemid 26401742)
2. Albini A, Ferrini S, Benelli R, Sforzini S, Giunciuglio D, Aluigi MG, Proudfoot AE, Alouani S, Wells TN, Mariani G, Rabin RL, Farber JM, Noonan DM. 1998. HIV-1 TAT protein mimicry of chemokines. Proc Natl Acad Sci USA 95:13153-13158.
3. Allan SM, Tyrrell PJ, Rothwell NJ. 2005. Interleukin-1 and neuronal injury. Nat Rev Immunol 5:629-640.
4. Ambrosino C, Ruocco MR, Chen X, Mallardo M, Baudi F, Trematerra S, Quinto I, Venuta S, Scala G. 1997. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta/NF-IL6) transcription factors. J Biol Chem 272:14883-14892.
5. Aquaro S, Svicher V, Ronga L, Perno CF, Pollicita M. 2008. HIV-1-associated dementia during HAART therapy. Recent Pat CNS Drug Discov 3:23-33.
6. Arai H, Charo IF. 1996. Differential regulation of G-protein-mediated signaling by chemokine receptors. J Biol Chem 271:21814-21819. (Pubitemid 26303800)
7. Bennasser Y, Badou A, Tkaczuk J, Bahraoui E. 2002. Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-α. Virology 303:174-180. (Pubitemid 36027176)
8. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y. 2001. SP600125, an anthrapyrazolone inhibitor of jun n-terminal kinase. Proc Natl Acad Sci USA 98:13681-13686.
9. Blazquez MV, Macho A, Ortiz C, Lucena C, Lopez-Cabrera M, Sanchez-Madrid F, Munoz E. 1999. Extracellular HIV type 1 Tat protein induces CD69 expression through NF-κB activation: Possible correlation with cell surface Tat-binding proteins. AIDS Res Hum Retroviruses 15:1209.
10. Brabers NA, Nottet HS. 2006. Role of the pro-inflammatory cytokines TNF-α and IL-1β in HIV-1-associated dementia. Eur J Clin Invest 36:447-4458.
11. Brigino E, Haraguchi S, Koutsonikolis A, Cianciolo GJ, Owens U, Good RA, Day NK. 1997. Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway. Proc Natl Acad Sci USA 94:3178-3182. (Pubitemid 27157284)
12. Cheung R, Ravyn V, Wang L, Ptasznik A, Collman RG. 2008. Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. J Immunol 180:6675-6684.
13. Cogswell JP, Godlevski MM, Wisely GB, Clay WC, Leesnitzer LM, Ways JP, Gray JG. 1994. NF-kB regulates IL-1beta transcription through a consensus NF-kB binding site and a nonconsensus CRE-like site. J Immunol 153:712-723. (Pubitemid 2129464)
14. Conant C, Ma M, Nath A, Major EO. 1996. Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes. J Virol 70:1384.
15. Demarchi F, d'Adda di Fagagna F, Falaschi A, Giacca M. 1996. Activation of transcription factor NF- kappa B by the Tat protein of human immunodeficiency virus type 1. J Virol 70:4427-4437.
16. Deregibus MC, Cantaluppi V, Doublier S, Brizzi MF, Deambrosis I, Albini A, Camussi G. 2002. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J Biol Chem 277:25195-25202. (Pubitemid 34951826)
17. Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type-1 Tat protein on cell growth and viral transactivation. J Virol 67:277-287. (Pubitemid 23002988)
18. Erickson RL, Hemati N, Ross SE, MacDougald OA. 2001. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. J Biol Chem 276:16348-16355. (Pubitemid 33652266)
19. Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A. 1989. Human immunodeficiency virus type 1 infection of the central nervous system: An evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol 23:109-116. (Pubitemid 19144791)
20. Ganju RK, Munshi N, Nair BC, Liu ZY, Gill P, Groopman JE. 1998. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor mitogen activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells. J Virol 72:6131-6137. (Pubitemid 28283403)
21. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C. 2001. Neuropathology and neurodegeneration in human immunodeficiency virus infection: Pathogenesis of HIV-induced lesions of the brain: Correlations with HIV-associated disorders, and modifications according to treatments. Clin Neuropathol 20:146-155.
22. Griffin WS, Sheng JG, Roberts GW, Mrak RE. 1995. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 54: 276-281.
23. Griffin WS, Liu L, Li Y, Mrak RE, Barger SW. 2006. Interleukin-1 mediates Alzheimer and Lewy body pathologies. JNeuroinflammation 3:5.
24. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G. 1993. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: Evidence for a positive autoregulatory loop. Mol Cell Biol 13:6231-6240. (Pubitemid 23292617)
25. Jones M, Olafson K, Del Bigio MR, Peeling J, Nath. A. 1998. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J Neuropathol Exp Neurol 57:563-570. (Pubitemid 28265599)
26. Kim SH, Smith CJ, Van Eldik LJ. 2004. Importance of MAPK pathways for microglial pro-inflammatory cytokine I IL-1β production. Neurobiol Aging 25:431-439.
27. Kinga JE, Eugenina EA, Bucknera CM, Berman JW. 2006. HIV tat and neurotoxicity. Microbes Infect 8:1347-1357.
28. Kruman PH, Nath A, Mattson MP. 1998. HIV-1 protein tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154:276-288. (Pubitemid 29044201)
29. Merrill JE, Koyanagi Y, Chen IS. 1989. Interleukin-1 and tumor necrosis factor can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 63:4404-4408. (Pubitemid 19229439)
30. Mischiati C, Pironi F, Milani D, Giacca M, Mirandola P, Capitani S, Zauli G. 1999. Extracellular HIV-1 Tat protein differentially activates the JNK and ERK/MAPK pathways in CD4 T cells. AIDS 13:1637-1645. (Pubitemid 30015710)
31. Moynagh PN. 2005. The interleukin-1 signalling pathway in astrocytes: Key contributor to inflammation in the brain. J Anat 207: 265-269.
32. Nath A. 2002. Human immunodeficiency virus(HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186:193-198.
33. Nath A, Conant K, Chen P, Scott C, Major EO. 1999. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. J Biol Chem 274:17098-17102. (Pubitemid 29275169)
34. Nuovo GJ, Alfieri ML. 1996. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 2:358-366.
35. Price RW, Brew BJ. 1988. The AIDS dementia complex. J Infect Dis 158:1079-1083.
36. Pu H, Tian J, Flora G, Lee YW, Nath A, Hennig B, Toborek M. 2003. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol Cell Neurosci 24: 224-237. (Pubitemid 37194547)
37. Ramji DP, Foka P. 2002. CCAAT/enhancer-binding proteins: Structure, function and regulation. Biochem J 365:561-575. (Pubitemid 34864439)
38. Rhee SG. 2001. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70:281-312.
39. Rothwell NJ, Luheshi GN. 2000. Interleukin 1 in the brain: Biology, pathology and therapeutic target. Trends Neurosci 23:618-625. (Pubitemid 32007888)
40. Singh IN, Hage El, Campbell ME, Lutz SE, Knapp PE, Nath A, Hauser KF. 2005. Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons. Neuroscience 135:781-790. (Pubitemid 41407741)
41. Smale ST, Fisher AG. 2002. Chromatin structure and gene regulation in the immune system. Annu Rev Immunol 20:427-462. (Pubitemid 34293431)
42. Tsukada J, Saito K, Waterman WR, Webb AC, Auron PE. 1994. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1b gene. Mol Cell Biol 14:7285.
43. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE. 1992. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31:349-3460.
44. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein JH, Walczak KM, Krammer PH. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500.
45. Wiley CA, Masliah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R. 1991. Neocortical damage during HIV infection. Ann Neurol 29:651-657.
46. Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT. 2000. Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci USA 97:11466-11471.
47. Zauli G, La Placa M, Vignoli M, Re MC, Gibellini D, Furlini G, Milani D, Marchisio M, Mazzoni M, Capitani S. 1995. An autocrine loop of HIV Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal human immunodeficiency virus type 1 long terminal repeat transactivating activity. J Acquir Immune Defic Syndr 10:306-316.
48. Zhang Y, Rom WN. 1993. Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol Cell Biol 13:3831-3837. (Pubitemid 23157320)
49. Zhao ML, Kim MO, Morgello S, Lee SC. 2001. Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 inHIV-1 encephalitis. J Neuroimmunol 115:182-191. (Pubitemid 32245667)
50. Zidovetzki R, Wang JL, Chen P, Jeyaseelan R, Hofman F. 1998. Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C and cAMP-dependent protein kinase pathways. AIDS Res Hum Retroviruses 4:825-833.